Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 12, 2011
Characterization of a stable, hypertensive rat model suitable for the consecutive evaluation of human renin inhibitorsRené St-Jacques, Sylvie Toulmond, Anick Auger, et al.The Journal of Pharmacology and Experimental Therapeutics|September 11, 2008
Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonistMarc Iglarz, Christoph Binkert, Keith Morrison, et al.European Radiology|April 5, 2017
Bacterial contamination of ultrasound probes in different radiological institutions before and after specific hygiene training: do we have a general hygienical problem?Thomas Sartoretti, Elisabeth Sartoretti, Candid Bucher, et al.Journal of Medicinal Chemistry|August 7, 2012
The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonistMartin H Bolli, Christoph Boss, Christoph Binkert, et al.Cardiovascular and Interventional Radiology|February 17, 2026
Intravascular Lithotripsy for Patients with Chronic Limb-Threatening Ischemia: Study Protocol for CALCIO, a Prospective Multicenter Observational InvestigationRaman Uberoi, Peter Reimer, Joo-Young Chun, et al.Journal of Medicinal Chemistry|May 14, 2004
Novel benzo[1,4]diazepin-2-one derivatives as endothelin receptor antagonistsMartin H Bolli, Judith Marfurt, Corinna Grisostomi, et al.Frontiers in Neurology|January 11, 2020
Amide Proton Transfer Weighted Imaging Shows Differences in Multiple Sclerosis Lesions and White Matter Hyperintensities of Presumed Vascular OriginElisabeth Sartoretti, Thomas Sartoretti, Michael Wyss, et al.Bioorganic & Medicinal Chemistry Letters|October 27, 2009
New classes of potent and bioavailable human renin inhibitorsL'ubos Remen, Olivier Bezençon, Sylvia Richard-Bildstein, et al.Journal of Medicinal Chemistry|April 11, 2009
Design and preparation of potent, nonpeptidic, bioavailable renin inhibitorsOlivier Bezençon, Daniel Bur, Thomas Weller, et al.The Journal of Infectious Diseases|June 27, 2012
Identification of a new chemical class of antimalarialsRalf Brunner, Hamed Aissaoui, Christoph Boss, et al.Pageof 5